tiprankstipranks

Gregory Scott Duncan Insider Profile

11 Followers
Gregory Scott Duncan, Director at Cormedix, holds ― shares in Cormedix (Ticker: CRMD), holds 57.46K shares in Virios Therapeutics (Ticker: VIRI). Most recently, Gregory Scott Duncan ― shares of Cormedix on ― for an estimated value of ―.
tipranks
Gregory Scott Duncan

Gregory Scott Duncan
Cormedix (CRMD)
Director

Ranked #93,006 out of 98,624 Corporate Insiders

Profitable Transactions

0%
0 out of 4 Profitable Transactions

Average Return

-64.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$24K
100.00%
0.00%
A breakdown of Gregory Scott Duncan's holdings

Insider Roles

Virios Therapeutics
(VIRI)
CEO, Director
Cormedix
(CRMD)
Director
Roles that Gregory Scott Duncan holds in companies

Most Profitable Insider Trade

Stock:
Virios Therapeutics
(VIRI)
Rating:Informative Buy
Date:Jan 08, 2021 - Jan 08, 2022
Return:-32.60%
The most profitable trade made by Gregory Scott Duncan

Gregory Scott Duncan's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Cormedix
Director
Virios Therapeutics
Aug 18, 2023
CEO, Director
Informative Buy
31.00K
$23.62K
List of latest transactions for each holding click on a transaction to see Gregory Scott Duncan's performance on stock

Gregory Scott Duncan insider profile FAQ

What is the percentage of profitable transactions made by Gregory Scott Duncan?
The percentage of profitable transactions made by Gregory Scott Duncan is 0%.
    What is the average return per transaction made by Gregory Scott Duncan?
    The average return per transaction made by Gregory Scott Duncan is -64.40%.
      What stocks does Gregory Scott Duncan hold?
      Gregory Scott Duncan holds: CRMD, VIRI stocks.
        What was Gregory Scott Duncan’s latest transaction?
        Gregory Scott Duncan latest transaction was an Uninformative Buy of ―.
          What was Gregory Scott Duncan's most profitable transaction?
          Gregory Scott Duncan’s most profitable transaction was an Informative Buy of VIRI stock on January 8, 2021. The return on the trade was -32.60%.
            What is Gregory Scott Duncan's role in Cormedix?
            Gregory Scott Duncan's role in Cormedix is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.